{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T03:01:07Z","timestamp":1781233267345,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.vaccine.2010.10.076","type":"journal-article","created":{"date-parts":[[2010,11,13]],"date-time":"2010-11-13T09:27:15Z","timestamp":1289640435000},"page":"451-458","source":"Crossref","is-referenced-by-count":35,"title":["\u201cOnce Bitten, Twice Shy\u201d: Participant perspectives in the aftermath of an early HIV vaccine trial termination"],"prefix":"10.1016","volume":"29","author":[{"given":"P.A.","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Walisser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Halpenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Loutfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"361","key":"10.1016\/j.vaccine.2010.10.076_bib0005","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa0908492","article-title":"Vaccination with ALVAC and AIDSVAX to prevent HIV-1 Infection in Thailand","volume":"23","author":"Rerks-Ngarm","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0010","unstructured":"Michael N. RV 144 Update: Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thai Adults. 17th Conference on retroviruses and opportunistic infections (CROI): Abstract 74. Presented February 18, 2010 http:\/\/retroconference.org\/2010\/Abstracts\/39837.htm."},{"key":"10.1016\/j.vaccine.2010.10.076_bib0015","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature07352","article-title":"Challenges in the development of an HIV-1 vaccine","volume":"455","author":"Barouch","year":"2008","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.vaccine.2010.10.076_bib0020","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1056\/NEJMe0909972","article-title":"HIV vaccine trial results\u2014an opening for further research","volume":"361","author":"Dolin","year":"2009","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2010.10.076_bib0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.vaccine.2007.12.016","article-title":"Community heroes or \u2018high-risk\u2019 pariahs? Reasons for declining to enroll in an HIV vaccine trial","volume":"26","author":"Newman","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/15381500903396857","article-title":"Social and behavioral challenges of HIV vaccines: implications for social work and social science","volume":"8","author":"Newman","year":"2009","journal-title":"Journal of HIV\/AIDS & Social Services"},{"issue":"9653","key":"10.1016\/j.vaccine.2010.10.076_bib0035","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0040","unstructured":"Vaccination and enrollment are discontinued in Phase II trials of Merck's investigational HIV vaccine candidate. News release. Sept 21, 2007. Available at: http:\/\/www.hvtn.org\/pdf\/FINAL_HIV_Vaccine_Press_Release.pdf."},{"key":"10.1016\/j.vaccine.2010.10.076_bib0045","unstructured":"STEP Study volunteers to be informed whether they received vaccine or placebo. News release Nov 13, 2007. Available at: http:\/\/www.hvtn.org\/media\/pr\/step111307.html."},{"issue":"1","key":"10.1016\/j.vaccine.2010.10.076_bib0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAD.0b013e32830e6d6d","article-title":"Post-step modification for research on HIV vaccines","volume":"23","author":"Corey","year":"2009","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.vaccine.2010.10.076_bib0055","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/01.qai.0000179454.93443.60","article-title":"HIV vaccine trial participation among ethnic minority communities","volume":"41","author":"Newman","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"10.1016\/j.vaccine.2010.10.076_bib0060","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.socscimed.2007.10.019","article-title":"Social impact of preventive vaccine clinical trial participation: a model of prevention, assessment and intervention","volume":"66","author":"Allen","year":"2008","journal-title":"Soc Sci Med"},{"issue":"5","key":"10.1016\/j.vaccine.2010.10.076_bib0065","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00042560-200008150-00010","article-title":"Readiness for HIV vaccine trials: Changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol Team","volume":"24","author":"Koblin","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0070","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1097\/00002030-200411190-00003","article-title":"Barriers to participating in an HIV vaccine trial: a systematic review","volume":"18","author":"Mills","year":"2004","journal-title":"AIDS"},{"issue":"17","key":"10.1016\/j.vaccine.2010.10.076_bib0075","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1001\/archinte.160.17.2614","article-title":"Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus","volume":"160","author":"Turner","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0080","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1001\/archinte.162.21.2458","article-title":"Distrust, race and research","volume":"162","author":"Corbie-Smith","year":"2002","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.vaccine.2010.10.076_bib0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1521\/aeap.2006.18.6.560","article-title":"How should HIV vaccine efficacy trials be conducted? Diverse U.S. communities speak out","volume":"18","author":"Kegeles","year":"2006","journal-title":"AIDS Educ Prev"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0090","series-title":"Naturalistic inquiry","author":"Lincoln","year":"1985"},{"issue":"7226","key":"10.1016\/j.vaccine.2010.10.076_bib0095","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1136\/bmj.320.7226.50","article-title":"Qualitative research in health care: assessing quality in qualitative research","volume":"320","author":"Mays","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0100","series-title":"Constructing grounded theory. A practical guide through qualitative analysis.","author":"Charmaz","year":"2006"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0105","series-title":"Theoretical sensitivity: advances in the methodology of grounded theory","author":"Glaser","year":"1978"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0110","unstructured":"HVTN 504 \u2013 Observational follow-up of adult participants enrolled in the Step Study (Merck V520 Protocol 023\/HVTN 502). Available at www.hivinfrosource.org\/hivis\/clinicaltrials\/prevention\/hvtn504.html."},{"key":"10.1016\/j.vaccine.2010.10.076_bib0115","unstructured":"HIV Vaccine Trials Network. Press release: Step Study follow-up complete\u2014First analyses presented at AIDS Vaccine 2010. Available at http:\/\/www.hvtn.org\/media\/pr\/stepfollowup.html."},{"key":"10.1016\/j.vaccine.2010.10.076_bib0120","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bmj.317.7167.1177","article-title":"Random allocation or allocation at random? Patients\u2019 perspectives of participation in a randomised controlled trial","volume":"317","author":"Featherstone","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0125","first-page":"3","article-title":"Methods of consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material (review)","author":"Nilsen","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0130","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/01.qai.0000247225.37752.f5","article-title":"Beyond the checklist: assessing understanding for HIV vaccine trial participation in South Africa","volume":"43","author":"Lindegger","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9507","key":"10.1016\/j.vaccine.2010.10.076_bib0135","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0140-6736(06)68067-7","article-title":"Towards a science of community engagement","volume":"367","author":"Newman","year":"2006","journal-title":"Lancet"},{"issue":"48","key":"10.1016\/j.vaccine.2010.10.076_bib0140","doi-asserted-by":"crossref","DOI":"10.3310\/hta11480","article-title":"Recruitment to randomised trials: strategies for trial enrolment and participation study. The STEPS study","volume":"11","author":"Campbell","year":"2007","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0145","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/OAJCT.S11915","article-title":"Time will tell: community acceptability of HIV vaccine research before and after the \u201cStep Study\u201d vaccine discontinuation","volume":"2","author":"Frew","year":"2010","journal-title":"Open Access J Clin Trials"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0150","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ypmed.2006.12.007","article-title":"Willingness to participate in HIV vaccine trials among communities at risk: the impact of trial attributes","volume":"44","author":"Newman","year":"2007","journal-title":"Prev Med"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0155","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/00126334-200405010-00009","article-title":"Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation","volume":"36","author":"Buchbinder","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2010.10.076_bib0160","doi-asserted-by":"crossref","first-page":"P217","DOI":"10.1186\/1742-4690-6-S3-P217","article-title":"Social factors affecting retention rates in Step study participants in Lima-Peru","volume":"6","author":"Fernandez-Maldonado","year":"2009","journal-title":"Retrovirology"},{"issue":"35","key":"10.1016\/j.vaccine.2010.10.076_bib0165","doi-asserted-by":"crossref","DOI":"10.3310\/hta9350","article-title":"Conceptual framework and systematic review of the effects of participants\u2019 and professionals\u2019 preferences in randomised controlled trials","volume":"9","author":"King","year":"2005","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2010.10.076_bib0170","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/1090198107305078","article-title":"A small dose of HIV? HIV vaccine mental models and risk communication","volume":"36","author":"Newman","year":"2009","journal-title":"Health Educ Behav"},{"issue":"20","key":"10.1016\/j.vaccine.2010.10.076_bib0175","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1016\/j.vaccine.2008.03.004","article-title":"What can HIV vaccine trials teach us about dissemination?","volume":"26","author":"Newman","year":"2008","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10015896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,13]],"date-time":"2021-11-13T14:05:05Z","timestamp":1636812305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10015896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0264410X10015896"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.10.076","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}